This inventor holds 6 USPTO granted patents and 12 published patent applications, plus 2 CIPO patents and 7 EPO patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2015-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2023
Title: The Innovative Contributions of Gwen Nichols
Introduction
Gwen Nichols is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of new dosage regimens for anti-tumor compounds. With a total of 6 patents to her name, her work has had a meaningful impact on cancer treatment methodologies.
Latest Patents
Among her latest patents is a method for administration that provides a new dosage regimen for Compound A. This innovative approach maximizes anti-tumor activity while maintaining acceptable toxicity levels. Her research continues to push the boundaries of what is possible in cancer therapy.
Career Highlights
Gwen has worked with notable companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Brian Higgins and Kathryn Elizabeth Packman. Their collaborative efforts have further advanced the research and development of effective cancer treatments.
Conclusion
Gwen Nichols is a trailblazer in the field of pharmaceuticals, with her innovative patents and collaborations paving the way for advancements in cancer treatment. Her contributions are invaluable to the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile